Seriously 'Sinister' Big Pharma: Opioid Maker Bankrolls Opposition to Pro-Pot Referendum
It has been revealed that the maker of a powerful, addictive opioid drug is bankrolling the opposition to the effort to legalize and regulate marijuana for recreational use in Arizona.
The Phoenix New Times reported Thursday that Insys Therapeutics, the company behind the fentanyl-based medication Subsys, made a $500,000 donation to the group Arizonans for Responsible Drug Policy (ARDP), which is leading the campaign against Proposition 205.
Click Here: camiseta seleccion argentina
On the ballot in November, Prop. 205 would allow people 21 years of age or older to possess up to one ounce of marijuana and grow up to six plants in their homes as well as establish a department to regulate the drug’s cultivation and sale.
It appears that Insys is trying to “eliminate the competition,” according to the New Times, which noted that the company “expects to soon launch a pharmaceutical version of THC, the main psychoactive ingredient in cannabis.”
What’s more, Insys is currently facing numerous state investigations for deceptively marketing and selling Subsys, which is intended to treat cancer pain, and coercing doctors to promote it to patients for off-label uses. Fentanyl is estimated to be 80 times as potent as morphine and hundreds of times more potent than heroin, according to the Centers for Disease Control and Prevention, and may be fatal to users.
SCROLL TO CONTINUE WITH CONTENT